ARCHIVES

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 16 No. 06 | February 9, 1990

Download PDF Visit The Full Archive

Related Articles

In Brief: Cooper Wouldn’t Take NIH Job, Says No One Has Asked Him To Take Top Health Spot

February 7, 1975

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

October 29, 2004

NCI May Seek Cuts In R01s, P01s If Congress Approves Rescission

January 30, 1981

RFA: Clinical Correlative Studies In Solid Tumors

April 3, 1992

Lenalidomide Maintenance Increased PFS and Survival

May 25, 2012

NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues

February 12, 1993